The spectrum of celiac disease: epidemiology, clinical aspects and treatment (Q34102794)

31 July 2017

1 reference

title

The spectrum of celiac disease: epidemiology, clinical aspects and treatment (English)

1 reference

31 July 2017

1 reference

Greetje J Tack

1

1 reference

31 July 2017

Wieke H M Verbeek

series ordinal

2

1 reference

31 July 2017

Marco W J Schreurs

series ordinal

3

1 reference

31 July 2017

Chris J J Mulder

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

9 March 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

31 July 2017

1 reference

31 July 2017

7

1 reference

31 July 2017

204-213

1 reference

31 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.23

31 July 2017

0 references

cites work

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac disease in Tunisia: serological screening in healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Successful treatment of refractory sprue with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

A History of Coeliac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Increasing prevalence of coeliac disease over time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of Celiac disease among children in Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac disease without villous atrophy: revision of criteria called for

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Gluten challenge in borderline gluten-sensitive enteropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease in the year 2000: exploring the iceberg

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Trends in the presentation of celiac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The Influence of Gluten: Weaning Recommendations for Healthy Children and Children at Risk for Celiac Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Infectious associations of Celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Infections may have a protective role in the etiopathogenesis of celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Lower economic status and inferior hygienic environment may protect against celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Replication of celiac disease UK genome-wide association study results in a US population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Newly identified genetic risk variants for celiac disease related to the immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The MYO9B Gene Is a Strong Risk Factor for Developing Refractory Celiac Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease in the Asia-Pacific region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Why is coeliac disease endemic in the people of the Sahara?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease among school children in Punjab, North India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease in developing countries: Middle East, India and North Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Characteristics of adult celiac disease in the USA: results of a national survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

A prospective study of the incidence of childhood celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac disease diagnosed in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Changing pattern of childhood coeliac disease in Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease--associated disorders and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease in Williams syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Italian paediatricians' approach to coeliac disease diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The absence of a mucosal lesion on standard histological examination does not exclude diagnosis of celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The diagnostic accuracy of serologic tests for celiac disease: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Selective IgA deficiency and coeliac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

HLA-DQ typing in the diagnosis of celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Genetic testing before serologic screening in relatives of patients with celiac disease as a cost containment method.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Nutritional Management of the Gluten-free Diet in Young People with Celiac Disease in The Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Factors that impact health-related quality of life in adults with celiac disease: a multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Patient perceptions of the burden of coeliac disease and its treatment in the UK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

New therapeutic strategies for celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Delayed diagnosis of coeliac disease increases cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Clinical staging and survival in refractory celiac disease: a single center experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Azathioprine and prednisone combination therapy in refractory coeliac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Novel approaches in the management of refractory celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Cladribine therapy in refractory celiac disease with aberrant T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Association of celiac disease and intestinal lymphomas and other cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The serologic screening for celiac disease in the general population (blood donors) and in some high-risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech republic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

[Prevalence of asymptommatic coeliac disease in children and adults in the Dresden region of Germany]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Seroprevalence, correlates, and characteristics of undetected coeliac disease in England

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Undiagnosed coeliac disease at age seven: population based prospective birth cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The smaller size of the 'coeliac iceberg' in adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of coeliac disease in Northern Ireland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Serological screening for celiac disease in healthy 2.5-year-old children in Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease in The Netherlands.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

An iceberg of childhood coeliac disease in the Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease among blood donors in Brazil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac Disease Could be a Frequent Disease in Mexico: Prevalence of Tissue Transglutaminase Antibody in Healthy Blood Donors

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

31 March 2020

12 December 2020

High prevalence of coeliac disease in apparently healthy Iranian blood donors

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Celiac disease in children with diarrhea is more frequent than previously suspected

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease in the Rehovot-Ashdod region of Israel: incidence and ethnic distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Coeliac disease among children in Kuwait: difficulties in diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease in Turkish children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Adult coeliac disease: prevalence and clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Trichuris suis therapy in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Budesonide in the treatment of refractory celiac disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Alemtuzumab for refractory celiac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

A severe but reversible refractory sprue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Disappointing outcome of allogeneic hematopoietic SCT in two EATL patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.23

Dietary compliance in screening-detected coeliac disease adolescents.

31 March 2020

1 reference

12 December 2020

Prevalence of celiac disease in north Indian children

1 reference

12 December 2020

The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects

1 reference

12 December 2020

Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation

1 reference

12 December 2020

The influence of gluten: weaning recommendations for healthy children and children at risk for celiac disease

1 reference

12 December 2020

Azathioprine in refractory sprue: results from a prospective, open-label study

1 reference

12 December 2020

High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?

1 reference

12 December 2020

Contribution of the MHC region to the familial risk of coeliac disease

1 reference

12 December 2020

Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate?

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2010.23

1 reference

31 July 2017

1 reference